Picture of Geovax Labs logo

GOVX Geovax Labs Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Geovax Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18.6-14-26-25-21.5
Depreciation
Non-Cash Items0.4080.9021.070.5291.12
Unusual Items
Other Non-Cash Items
Changes in Working Capital6.93-5.97-0.356-0.307-2.51
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Cash from Operating Activities-11.2-19-25.2-24.7-22.8
Capital Expenditures-0.048-0.134-0.049-0.021-0.028
Purchase of Fixed Assets
Cash from Investing Activities-0.048-0.134-0.049-0.021-0.028
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities12.835.44.0623.819.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.5416.2-21.2-0.946-2.42